Inventor
YEDGAR SAUL
IL30 patents
⚠️ This page may combine multiple inventors who share the name “YEDGAR SAUL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
YISSUM RES DEV CO
15 patentsUS5064817ANov 12, 1991
Phospholipase a2 inhibiting compositions and their use
YISSUM RES DEV CO106 citations95
US7608598B2Oct 27, 2009
Use of lipid conjugates in the treatment of conjunctivitis
YISSUM RES DEV CO21 citations92
US7393938B2Jul 1, 2008
Use of lipid conjugates in the treatment of diseases
YISSUM RES DEV CO29 citations92
US5656501AAug 12, 1997
Flow cell device for monitoring blood or other cell suspension under flow
YISSUM RES DEV CO42 citations92
US7504384B2Mar 17, 2009
Use of lipid conjugates in the treatment of infection
YISSUM RES DEV CO25 citations90
US7141552B2Nov 28, 2006
Use of lipid conjugates in the treatment of diseases
YISSUM RES DEV CO36 citations89
US7101859B2Sep 5, 2006
Use of lipid conjugates in the treatment of diseases
YISSUM RES DEV CO46 citations87
US7034006B2Apr 25, 2006
Use of lipid conjugates in the treatment of disease
YISSUM RES DEV CO53 citations87
US8383787B2Feb 26, 2013
Use of lipid conjugates in the treatment of diseases
YISSUM RES DEV CO5 citations84
US7772196B2Aug 10, 2010
Use of lipid conjugates in the treatment of diseases
YISSUM RES DEV CO14 citations84
US7893226B2Feb 22, 2011
Use of lipid conjugates in the treatment of diseases
YISSUM RES DEV CO5 citations74
US9012396B2Apr 21, 2015
Use of lipid conjugates in the treatment of conjunctivitis
YISSUM RES DEV CO3 citations63
US8865878B2Oct 21, 2014
Use of lipid conjugates in the treatment of diseases
YISSUM RES DEV CO2 citations63
US8372815B2Feb 12, 2013
Use of lipid conjugates in the treatment of conjunctivitis
YISSUM RES DEV CO0 citations52
US7811999B2Oct 12, 2010
Use of lipid conjugates in the treatment of diseases
YISSUM RES DEV CO0 citations31
YEDGAR SAUL
11 patentsUS8916539B2Dec 23, 2014
Use of lipid conjugates in the treatment of disease
YEDGAR SAUL25 citations87
US10179106B2Jan 15, 2019
Liposomes comprising polymer-conjugated lipids and related uses
YEDGAR SAUL6 citations83
US8901103B2Dec 2, 2014
Use of lipid conjugates in the treatment of diseases
YEDGAR SAUL11 citations83
US8076312B2Dec 13, 2011
Use of lipid conjugates in the treatment of disease
YEDGAR SAUL12 citations83
US8906882B2Dec 9, 2014
Lipid conjugates in the treatment of allergic rhinitis
YEDGAR SAUL0 citations51
US8859524B2Oct 14, 2014
Lipid conjugates in the treatment of chronic rhinosinusitis
YEDGAR SAUL1 citations51
US8501701B2Aug 6, 2013
Use of lipid conjugates in the treatment of disease
YEDGAR SAUL0 citations49
US9040078B2May 26, 2015
Use of lipid conjugates in the treatment of diseases of the nervous system
YEDGAR SAUL0 citations41
US8883761B2Nov 11, 2014
Use of lipid conjugates in the treatment of diseases associated with vasculature
YEDGAR SAUL0 citations41
US8865681B2Oct 21, 2014
Use of lipid conjugates in the treatment of diseases or disorders of the eye
YEDGAR SAUL0 citations41
US8304395B2Nov 6, 2012
Lipid conjugates in the treatment of disease
YEDGAR SAUL0 citations41
YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD
4 patentsUS10624851B2Apr 21, 2020
Liposomes comprising polymer-conjugated lipids and related uses
YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD4 citations84
US11911507B2Feb 27, 2024
Liposomes comprising polymer-conjugated lipids and related uses
YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD0 citations62
US11013811B2May 25, 2021
Lipid-polymer conjugates, their preparation and uses thereof
YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD0 citations62
US12042273B2Jul 23, 2024
System and method for non-invasive monitoring of blood conditions
YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD0 citations45